Curcumin and its therapeutic potential in inflammatory bowel disease: A systematic review
DOI:
https://doi.org/10.33448/rsd-v15i3.50781Keywords:
Curcumin, Curcuma longa, Inflammatory bowel disease, Natural anti-inflammatories, Complementary therapies.Abstract
Inflammatory bowel diseases (IBDs), such as Crohn's disease and ulcerative colitis, are chronic conditions characterized by persistent inflammation of the gastrointestinal tract, generating functional and psychological impacts on patients' lives. In this context, an alternative that has been widely studied in relation to treatment and diagnosis is the compound *Curcuma longa*, especially for its therapeutic potential related to its anti-inflammatory, antioxidant, and immunomodulatory properties. This systematic review aimed to gather and analyze recent scientific evidence on the effects of curcumin in the treatment of IBDs. Eighteen articles published between 2020 and 2025 in the PubMed, SciELO, and Virtual Health Library (BVS) databases were selected, evaluating the efficacy of curcumin alone or combined with piperine. The results demonstrated significant benefits in reducing intestinal inflammation, clinical improvement of symptoms, and a favorable safety profile. However, limitations such as low bioavailability and methodological heterogeneity among the studies indicate the need for more controlled clinical trials. Curcumin shows promise as an adjunct treatment for IBDs, provided its use is guided by robust evidence and professional monitoring.
References
Abraham, C., & Cho, J. H. (2009). Inflammatory bowel disease. New England Journal of Medicine, 361(21), 2066–2078. https://doi.org/10.1056/NEJMra0804647
Al-Bawardy, B., et al. (2021). Health-related quality of life and disease burden in inflammatory bowel disease. Clinical Gastroenterology and Hepatology, 1044–1052.
Alves, F. R. (2021). Revisão sistemática dos efeitos da curcumina nas doenças inflamatórias intestinais. Revista de Fitoterapia e Saúde, 7(2), 45–56.
Alves, M. P. A. C. (2022). O efeito anti-inflamatório da Curcuma longa nas doenças inflamatórias intestinais: Uma revisão sistemática. Revista Ibero-Americana de Humanidades, Ciências e Educação, 8(6), 1533–1545.
Avasarala, S., Zhang, F., Liu, G., Wang, R., London, S. D., & London, L. (2013). Curcumin modulates the inflammatory response and oxidative stress in inflammatory bowel disease. Clinical and Experimental Immunology, 174(2), 153–162. https://doi.org/10.1111/cei.12153
Bodini, G., et al. (2021). Impact of inflammatory bowel disease on daily life: Real-world data from a multicenter cohort study. Digestive and Liver Disease, 216–222. https://doi.org/10.1016/j.dld.2020.08.026
Brasil. Ministério da Saúde. (2020). Informações sistematizadas da relação nacional de plantas medicinais de interesse ao SUS: Curcuma longa L., Zingiberaceae – açafrão-da-terra. https://bvsms.saude.gov.br
Carneiro, J. A., & Macedo, D. S. (2020). Cúrcuma: Princípios ativos e seus benefícios para a saúde. Revista Brasileira de Obesidade, Nutrição e Emagrecimento, 14(87), 632–640.
Cheng, Y., et al. (2022). Curcumin ameliorates colitis by regulating gut microbiota and the balance of Th17/Treg cells. Frontiers in Pharmacology, 13, 849107. https://doi.org/10.3389/fphar.2022.849107
Coelho, R. C., et al. (2020). Curcumina como adjuvante no tratamento da retocolite ulcerativa: Revisão sistemática. Revista Brasileira de Gastroenterologia, 27(3), 211–218.
Crossetti, M. G. O. (2012). Revisão integrativa de pesquisa na enfermagem: O rigor científico que lhe é exigido. Revista Gaúcha de Enfermagem, 33(2), 8–9.
Goulart, L. M., et al. (2020). Efeitos da curcumina na atividade clínica e endoscópica da retocolite ulcerativa: Uma revisão sistemática. Jornal Brasileiro de Coloproctologia, 40(1), 20–29.
Gowd, V., et al. (2023). Resveratrol and resveratrol nano-delivery systems in the treatment of inflammatory bowel disease. Journal of Nutritional Biochemistry, 109, 109101.
Khor, B., et al. (2011). Genetics and pathogenesis of inflammatory bowel disease. Nature, 474, 307–317. https://doi.org/10.1038/nature10209
Kumar, D., et al. (2020). Nanotechnology-based approaches for enhancing oral bioavailability of curcumin in inflammatory bowel disease therapy. Journal of Drug Delivery Science and Technology, 57, 101620.
Lang, A., Salomon, N., Wu, J. C. Y., Kopylov, U., Lahat, A., Har-Noy, O., et al. (2015). Curcumin in combination with mesalamine induces remission in patients with mild-to-moderate ulcerative colitis in a randomized controlled trial. Clinical Gastroenterology and Hepatology, 13(8), 1444–1449. https://doi.org/10.1016/j.cgh.2015.02.019
Limketkai, B. N., & Iyengar, P. (2024). The use of curcumin in ulcerative colitis: Current evidence and practical applications. Practical Gastroenterology, 48(3).
Mazieiro, R., Frizon, R. R., Barbalho, S. M., & Goulart, R. A. (2018). Is curcumin a possibility to treat inflammatory bowel diseases? Journal of Medicinal Food, 21(11), 1077–1085. https://doi.org/10.1089/jmf.2017.0146
Memarzia, A., Sahebkar, A., & Hosseini, H. (2021). Curcumin and inflammatory bowel disease: Mechanisms of action and therapeutic potential. Phytotherapy Research, 35(3), 1345–1360. https://doi.org/10.1002/ptr.6909
Mirzaei, H., et al. (2020). The use of curcumin as a complementary therapy in ulcerative colitis: A systematic review of randomized controlled clinical trials. Nutrients, 12(8), 2296. https://doi.org/10.3390/nu12082296
Mohseni, S., et al. (2025). Curcumin for the clinical treatment of inflammatory bowel diseases: A systematic review and meta-analysis of placebo-controlled randomized clinical trials. Frontiers in Nutrition, 12, 1494351. https://doi.org/10.3389/fnut.2025.1494351
Nascimento, P. R. S., Silva Júnior, E. L., & Castelo Branco, A. C. S. (2020). Aplicações farmacológicas da Curcuma longa L. como planta medicinal: Uma revisão. Research, Society and Development, 9(11), e84301110366.
Oliveira, C. V. C., Oliveira, G. A., & Gonçalves, F. S. M. (2024). Melhoria da absorção e eficácia da curcumina pela associação com piperina na regulação de citocinas inflamatórias. Revista Foco, 17(11), 1–14.
Ordás, I., et al. (2012). Ulcerative colitis. The Lancet, 380(9853), 1606–1619. https://doi.org/10.1016/S0140-6736(12)60150-0
Page, M. J., McKenzie, J. E., Bossuyt, P. M., Boutron, I., Hoffmann, T. C., Mulrow, C. D., et al. (2021). The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. BMJ, 372, n71. https://doi.org/10.1136/bmj.n71
Peng, Y., Ao, M., Dong, B., Jiang, Y., Yu, L., Chen, Z., Hu, C., & Xu, R. (2021). Anti-inflammatory effects of curcumin in inflammatory diseases: Status, limitations and countermeasures. Drug Design, Development and Therapy, 15, 4503–4525.
Pereira, A. S., et al. (2018). Metodologia da pesquisa científica [Free ebook]. Editora da UFSM.
Rahaman, M. M., et al. (2021). The genus Curcuma and inflammation: Overview of the pharmacological perspectives. Plants, 10(1), 63. https://doi.org/10.3390/plants10010063
Risemberg, R. I. C., et al. (2026). A importância da metodologia científica no desenvolvimento de artigos científicos. E-Acadêmica, 7(1), e0171675.
Rocha, D. A., & Ferraz, A. R. (2022). Uso da cúrcuma no tratamento da doença inflamatória intestinal: Uma revisão integrativa. Research, Society and Development, 11(9), e18711931856.
Santos, C. H. M., et al. (2022). Uso da cúrcuma no tratamento da retocolite ulcerativa. Research, Society and Development, 11(5), e49411528480.
Silva, A. S. (2021). Potencial terapêutico da curcumina nas doenças inflamatórias intestinais: Revisão integrativa. Revista de Ciências Médicas e Biológicas, 20(1), 15–22.
Singh, S., et al. (2022). A review on selected pharmacological activities of Curcuma longa L. International Journal of Food Properties, 25(1), 1377–1398.
Singla, R. K., et al. (2022). Curcumin and its derivatives: A potential treatment for inflammatory bowel disease. Phytotherapy Research, 36(2), 825–841. https://doi.org/10.1002/ptr.7339
Snyder, H. (2019). Literature review as a research methodology: An overview and guidelines. Journal of Business Research, 104, 333–339. https://doi.org/10.1016/j.jbusres.2019.07.039
Srinivasan, V., et al. (2021). The efficacy of curcumin in the treatment of inflammatory bowel disease: A systematic review and meta-analysis. Nutrients, 13(4). https://doi.org/10.3390/nu13041149
Sugimoto, K., et al. (2020). Efficacy and safety of highly bioavailable curcumin for treating mild to moderate ulcerative colitis: A multicenter randomized, double-blind, placebo-controlled trial. Clinical Gastroenterology and Hepatology, 18(4), 822–829.
Suskind, D. L., et al. (2013). Tolerability of curcumin in pediatric inflammatory bowel disease: A forced dose titration study. Journal of Pediatric Gastroenterology and Nutrition, 56(3), 277–279.
Sueth-Santiago, V., et al. (2015). Curcumina: Uma revisão de seus efeitos farmacológicos e terapêuticos. Revista Brasileira de Plantas Medicinais, 17(4), 924–931.
Torres, J., et al. (2020). ECCO guidelines on therapeutics in Crohn’s disease: Medical treatment. Journal of Crohn’s and Colitis, 14(1), 4–22.
Ungaro, R., Mehandru, S., Allen, P. B., Peyrin-Biroulet, L., & Colombel, J. F. (2021). Ulcerative colitis. The Lancet, 397(10279), 1756–1770.
Victorio, M. E. L., Netto, S. L. C. B. M. A., Rezende, A. J., & Fortes, R. C. (2021). Cúrcuma e suas propriedades funcionais: Uma revisão integrativa. Brasília Médica, 58(1), 1–8.
Zendedel, A., Nobakht, M., & Sahebkar, A. (2024). Curcumin supplementation in patients with ulcerative colitis: A randomized clinical trial. Nutrients, 16(3), 450.
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Maria Eduarda de Souza Brustolin , Gabriela Dalberto
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
